S-O Andersson
- Health, Toxicology and Mutagenesis top 10%
- Pulmonary and Respiratory Medicine
- Oncology
- Molecular Biology
- Epidemiology
- Co-authors
- J-E JohanssonOve AndrénAlicja WolkBo CarlbergBettina JulinAgneta ÅkessonNicola OrsiniAnders Rane
- Topics
- Prostate Cancer Treatment and Research (4 papers)Radiopharmaceutical Chemistry and Applications (2 papers)Prostate Cancer Diagnosis and Treatment (2 papers)
- Partner nations
- SwedenUnited StatesItaly
In The Last Decade
S-O Andersson
11 papers receiving 403 citations
Peers
Comparison fields: 5 of 83
- Health, Toxicology and Mutagenesis 95
- Pulmonary and Respiratory Medicine 88
- Oncology 73
- Molecular Biology 71
- Epidemiology 64
Countries citing papers authored by S-O Andersson
This map shows the geographic impact of S-O Andersson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S-O Andersson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S-O Andersson more than expected).
Fields of papers citing papers by S-O Andersson
This network shows the impact of papers produced by S-O Andersson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S-O Andersson. The network helps show where S-O Andersson may publish in the future.
Co-authorship network of co-authors of S-O Andersson
This figure shows the co-authorship network connecting the top 25 collaborators of S-O Andersson. A scholar is included among the top collaborators of S-O Andersson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S-O Andersson. S-O Andersson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 113 | |
| 2 | 38 | |
| 3 | 66 | |
| 4 | Testing a multigene model to predict lethal prostate cancer | 1 |
| 5 | 23 | |
| 6 | 36 | |
| 7 | 64 | |
| 8 | 72 | |
| 9 | [Difficult patient-physician relations as a challenge full of nuances]. | 0 |
| 10 | Optimized urinary microscopy for assessment of bacteriuria in primary care. | 7 |
| 11 | Wait and see in early prostatic cancer. Preliminary report of a 7-year material of 223 patients. | 1 |
| 12 | 1 |
About S-O Andersson
S-O Andersson is a scholar working on Pharmacy, Clinical Biochemistry and Rehabilitation, having authored 12 papers that have together received 422 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (4 papers), Radiopharmaceutical Chemistry and Applications (2 papers) and Prostate Cancer Diagnosis and Treatment (2 papers). The work is most often cited by research in Rehabilitation (62 citations), Health, Toxicology and Mutagenesis (95 citations) and Pollution (55 citations). S-O Andersson has collaborated with scholars based in Sweden, United States and Italy. Frequent co-authors include J-E Johansson, Ove Andrén, Alicja Wolk, Bo Carlberg, Bettina Julin, Agneta Åkesson, Nicola Orsini, Anders Rane, Mats J. Olsson and Lena Ekström. Their work appears in journals such as British Journal of Cancer, Modern Pathology and Clinical Rehabilitation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.